sistema inmune 1 alx
TRANSCRIPT
![Page 1: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/1.jpg)
INMUNOBIOLOGÍA
![Page 2: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/2.jpg)
• La inmunología es una rama amplia de la biología y de las ciencias biomédicas que se ocupa del estudio del sistema inmunitario en todos los organismos, entendiendo como tal al conjunto de órganos, tejidos y células que en los vertebrados tienen como función biológica el reconocer elementos extraños o ajenos dando una respuesta (respuesta inmunológica).
![Page 3: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/3.jpg)
is widely credited as the pioneer of smallpox vaccine, and is sometimes referred to as the "Father of Immunology” 1770
Edward Jenner
![Page 4: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/4.jpg)
Cowpox is a skin disease caused by a virus known as the Cowpox virus. The pox is related to the vaccinia virus and got its name from the distribution of the disease when dairymaids touched the udders of infected cows. The ailment manifests itself in the form of red blisters and is transmitted by touch from infected animals to humans. Cowpox is similar to but much milder than the highly contagious and sometimes deadly smallpox disease. It resembles mild smallpox, and was the basis of the first smallpox vaccines. When the patient recovers from cowpox, the person is immune to smallpox.
![Page 5: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/5.jpg)
La viruela es una enfermedad infecciosa grave, contagiosa, causada por el Variola virus, que en algunos casos puede causar la muerte. No hay tratamiento especial para la viruela y la única forma de prevención es la vacunación. El nombre viruela proviene de la palabra latina que significa “manchado” y se refiere a los abultamientos que aparecen en la cara y en el cuerpo de una persona infectada. Según la OMS la viruela es la única enfermedad que está totalmente erradicada de todo el planeta.
![Page 6: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/6.jpg)
![Page 7: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/7.jpg)
![Page 8: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/8.jpg)
![Page 9: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/9.jpg)
![Page 10: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/10.jpg)
![Page 11: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/11.jpg)
![Page 12: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/12.jpg)
Figure 25-41The principal stages in complement activation by the classical, lectin, and alternative pathways
In all three pathways, the reactions of complement activation usually take place on the surface of an invading microbe, such as a bacterium. C1–C9 and factors B and D are the reacting components of the complement system; various other components regulate the system. The early components are shown within gray arrows, while the late components are shown within a brown arrow.
![Page 13: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/13.jpg)
Figure 25-42Assembly of the late complement components to form a membrane attack complex
When C3b is produced by any of the three activation pathways, it is immobilized on a membrane, where it causes the cleavage of the first of the late components, C5, to produce C5a (not shown) and C5b. C5b remains loosely bound to C3b (not shown) and rapidly assembles with C6 and C7 to form C567, which then binds firmly via C7 to the membrane, as illustrated. To this complex is added one molecule of C8 to form C5678. The binding of a molecule of C9 to C5678 induces a conformational change in C9 that exposes a hydrophobic region and causes C9 to insert into the lipid bilayer of the target cell. This starts a chain reaction in which the altered C9 binds a second molecule of C9, where it can bind another molecule of C9, and so on. In this way, a large transmembrane channel is formed by a chain of C9 molecules.
![Page 14: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/14.jpg)
![Page 15: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/15.jpg)
![Page 16: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/16.jpg)
![Page 17: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/17.jpg)
![Page 18: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/18.jpg)
Scanning electron micrograph of a phagocyte (yellow, right) phagocytosing anthrax bacilli (orange, left)
![Page 19: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/19.jpg)
![Page 20: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/20.jpg)
• MONOCITOS• 5% de leucocitos en sangre• Producen médula ósea y liberan a la sangre• Circulan por varias semanas y después
entran a los tejidos donde se desarrollan como MACRÓFAGOS.
• Tienen núcleo en forma de herradura bilobulado y citoplasma prominente.
• Importantes contra bacterias• Abundantes en pulmones, intestino, hígado
y bazo.
![Page 21: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/21.jpg)
![Page 22: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/22.jpg)
Leucocitos Polimorfonucleares• Son de tres tipos
![Page 23: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/23.jpg)
NeutrófilosCaracterística de tener un núcleo de
tres o más lóbulos
60% de leucocitos en la sangre
Son Fagocíticos
• Se producen en la médula ósea
• Abundantes en la sangre
• Vida corta
• Importantes en la inflamación, son los primeros en llegar al sitio dañado o lesión.
![Page 24: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/24.jpg)
• BASÓFILOS Núcleo bilobulado y gránulos prominentes
• Producen médula ósea y entran a la sangre
• Al entrar a tejido sólido se desarrollan en MASTOCITOS que se concentran en el tejido conectivo de los tractos respiratorio y gastrointetinales y en la piel.
• Ambos contienen gránulos que inician la inflamación que contienen HISTAMINA, el factor Quimiotáctico de Eosinófilos.
![Page 25: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/25.jpg)
HC=C-CH2-CH2-NH3+
N NH
C
H
Histamine
Características al MET: prolongaciones celulares cortas,gran desarrollo del A. Golgi, núcleo de bordes irregulares y numerososgránulos electrón densos.
![Page 26: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/26.jpg)
Eosinófilos
• Son 1-2% de los leucocitos de la sangre
• Gránulos prominentes contienen:
- Proteína Básica Principal
- Proteína Catiónica de Eosinófilos
- Peroxidasa de Eosinófilo
• Tóxicos para parásitos
![Page 27: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/27.jpg)
Células Asesinas Naturales
• 5-10% de leucocitos en la sangre
• Destruyen células infectadas por virus
• Se pegan a las células infectadas y liberan gránulos tóxicos que lisan a la célula
![Page 28: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/28.jpg)
![Page 29: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/29.jpg)
![Page 30: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/30.jpg)
![Page 31: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/31.jpg)
![Page 32: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/32.jpg)
![Page 33: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/33.jpg)
Fig. 11.13 Features of specific immunity (see text for details)
![Page 34: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/34.jpg)
![Page 35: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/35.jpg)
![Page 36: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/36.jpg)
![Page 37: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/37.jpg)
![Page 38: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/38.jpg)
![Page 39: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/39.jpg)
![Page 40: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/40.jpg)
![Page 41: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/41.jpg)
![Page 42: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/42.jpg)
![Page 43: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/43.jpg)
![Page 44: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/44.jpg)
![Page 45: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/45.jpg)
![Page 46: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/46.jpg)
![Page 47: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/47.jpg)
![Page 48: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/48.jpg)
![Page 49: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/49.jpg)
![Page 50: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/50.jpg)
![Page 51: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/51.jpg)
![Page 52: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/52.jpg)
![Page 53: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/53.jpg)
Each antibody binds to a specific antigen; an interaction similar to a lock and key.
![Page 54: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/54.jpg)
![Page 55: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/55.jpg)
![Page 56: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/56.jpg)
![Page 57: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/57.jpg)
![Page 58: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/58.jpg)
Figure 23-18 Fab and F(ab')2 antibody fragments
These fragments are produced when antibody molecules are cleaved with the proteolytic enzymes papain and pepsin, respectively.
![Page 59: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/59.jpg)
![Page 60: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/60.jpg)
![Page 61: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/61.jpg)
Figure 23-15Antibody-antigen interactions
Because antibodies have two identical antigen-binding sites, they can cross-link antigens. The types of antibody-antigen complexes that form depend on the number of antigenic determinants on the antigen. Here a single species of antibody (a monoclonal antibody) is shown binding to antigens containing one, two, or three copies of a single type of antigenic determinant. Antigens with two antigenic determinants can form small cyclic complexes or linear chains with antibody, while antigens with three or more antigenic determinants can form large three-dimensional lattices that readily precipitate out of solution. Most antigens have many different antigenic determinants (see Figure 23-25A) and the different antibodies that recognize these different determinants can cooperate in cross-linking the antigen (not shown).
![Page 62: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/62.jpg)
Figure 23-16The hinge region of an antibody molecule
Because of its flexibility, the hinge region improves the efficiency of antigen binding and cross-linking.
![Page 63: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/63.jpg)
Figure 23-19A pentameric IgM molecule
The five subunits are held together by disulfide bonds. A single J chain, which has a structure similar to that of a single Ig domain (discussed later), is disulfide-bonded between two μ heavy chains. The J chain is required for the polymerization process. The addition of each successive four-chain IgM subunit requires a J chain, which is then discarded, except for the last one, which is retained.
![Page 64: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/64.jpg)
Figure 23-21A highly schematized diagram of a dimeric IgA molecule found in secretions
In addition to the two IgA monomers, there is a single J chain and an additional polypeptide chain called the secretory component, which is thought to protect the IgA molecules from being digested by proteolytic enzymes in the secretions.
![Page 65: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/65.jpg)
![Page 66: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/66.jpg)
Figure 23-20Antibody-activated phagocytosis
An IgG-antibody-coated bacterium is efficiently phagocytosed by a macrophage or neutrophil, which has cell-surface receptors able to bind the Fc region of IgG molecules. The binding of the antibody-covered bacterium to these Fc receptors activates the phagocytic process.
![Page 67: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/67.jpg)
Figure 23-23 The role of IgE in histamine secretion by mast cells
A mast cell (or a basophil) binds IgE molecules after they are secreted by activated B cells; the soluble IgE antibodies bind to Fc receptor proteins on the mast cell surface that specifically recognize the Fc region of these antibodies. The passively acquired IgE molecules on the mast cell serve as cell-surface receptors for antigen. Thus, unlike B cells, each mast cell (and basophil) has a set of cell-surface antibodies with a wide variety of antigen-binding sites. When an antigen molecule binds to these membrane-bound IgE antibodies so as to cross-link them to their neighbors, it activates the mast cell to release its histamine by exocytosis.
![Page 68: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/68.jpg)
![Page 69: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/69.jpg)
![Page 70: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/70.jpg)
![Page 71: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/71.jpg)
![Page 72: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/72.jpg)
Figure 1.19Transmission electron micrographs of lymphocytes at various stages of activation to effector function
Small resting lymphocytes (top panel) have not yet encountered antigen. Note the scanty cytoplasm, the absence of rough endoplasmic reticulum, and the condensed chromatin, all indicative of an inactive cell. This could be either a T cell or a B cell. Small circulating lymphocytes are trapped in lymph nodes when their receptors encounter antigen on antigen-presenting cells. Stimulation by antigen induces the lymphocyte to become an active lymphoblast (center panel). Note the large size, the nucleoli, the enlarged nucleus with diffuse chromatin, and the active cytoplasm; again, T and B lymphoblasts are similar in appearance. This cell undergoes repeated division, which is followed by differentiation to effector function. The bottom panels show effector T and B lymphocytes. Note the large amount of cytoplasm, the nucleus with prominent nucleoli, abundant mitochondria, and the presence of rough endoplasmic reticulum, all hallmarks of active cells. The rough endoplasmic reticulum is especially prominent in plasma cells (effector B cells), which are synthesizing and secreting very large amounts of protein in the form of antibody. Photographs courtesy of N. Rooney.
![Page 73: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/73.jpg)
Figure 23-4Electron micrographs of resting and activated lymphocytes
The resting lymphocyte in (A) could be a T cell or a B cell, for these cells are difficult to distinguish morphologically until they have been activated. The activated B cell (a plasma cell) in (B) is filled with an extensive rough endoplasmic reticulum (ER), which is distended with antibody molecules. The activated T cell in (C) has relatively little rough ER but is filled with free ribosomes. Note that the three cells are shown at the same magnification. (A, courtesy of Dorothy Zucker-Franklin; B, courtesy of Carlo Grossi; A and B, from D. Zucker-Franklin et al., Atlas of Blood Cells: Function and Pathology, 2nd ed. Milan, Italy: Edi. Ermes, 1988; C, courtesy of Stefanello de Petris.)
![Page 74: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/74.jpg)
![Page 75: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/75.jpg)
![Page 76: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/76.jpg)
![Page 77: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/77.jpg)
Figure 23-6Two types of experiments that support the clonal selection theory
For simplicity, cell-surface receptors are shown only on those lymphocytes committed to respond to antigen A; in fact, however, all T and B cells have antigen-specific receptors on their surface. The experiments shown have been carried out mainly with B cells since T cells recognize an antigen only when it is bound to the surface of a host cell, as we discuss later.
![Page 78: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/78.jpg)
![Page 79: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/79.jpg)
![Page 80: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/80.jpg)
![Page 81: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/81.jpg)
![Page 82: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/82.jpg)
![Page 83: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/83.jpg)
![Page 84: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/84.jpg)
![Page 85: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/85.jpg)
![Page 86: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/86.jpg)
![Page 87: Sistema inmune 1 alx](https://reader038.vdocumento.com/reader038/viewer/2022102815/556e5672d8b42a2c658b519b/html5/thumbnails/87.jpg)